Kawasaki disease (KD) is an acute inflammatory illness marked by coronary
arteritis. However, the factors increasing susceptibility to coronary artery lesions are unknown. Because
transforming growth factor (TGF) β increases
elastin synthesis and suppresses proteolysis, we hypothesized that, in contrast to the benefit observed in
aneurysms forming in those with
Marfan syndrome, inhibition of TGF-β would worsen inflammatory-induced coronary artery lesions. By using a murine model of KD in which injection of Lactobacillus casei wall extract (LCWE) induces coronary
arteritis, we show that LCWE increased TGF-β signaling in the coronary smooth muscle cells beginning at 2 days and continuing through 14 days, the point of peak coronary
inflammation. By 42 days, LCWE caused fragmentation of the internal and external elastic lamina. Blocking TGF-β by administration of a
neutralizing antibody accentuated the LCWE-mediated fragmentation of
elastin and induced an overall loss of medial
elastin without increasing the inflammatory response. We attributed these increased pathological characteristics to a reduction in the proteolytic
inhibitor, plasminogen activator inhibitor-1, and an associated threefold increase in
matrix metalloproteinase 9 activity compared with LCWE alone. Therefore, our data demonstrate that in the coronary
arteritis associated with KD, TGF-β suppresses
elastin degradation by inhibiting
plasmin-mediated
matrix metalloproteinase 9 activation. Thus, strategies to block TGF-β, used in those with
Marfan syndrome, are unlikely to be beneficial and could be detrimental.